Hypertension – Friday Pop Quiz 9/29/2023
A 44-year-old man with a history of diabetes, hypertension, and major depressive disorder presents to the office with the eruption shown for several months. The lesions are also all across the patient's back and have not resolved with twice-daily clobetasol 0.05% ointment application for 2 months. Which of the following is the most appropriate treatment?
A. Intralesional triamcinolone
B. Nar …
A 44-year-old man with a history of diabetes, hypertension, and major depressive disorder presents to the office with the eruption shown for several months. The lesions are also all across the patient's back and have not resolved with twice-daily clobetasol 0.05% ointment application for 2 months. Which of the following is the most appropriate treatment?
A. Intralesional triamcinolone
B. Nar … 
Intravenous immune globulin (IVIG) is a concentrate of pooled immunoglobulins derived from plasma donors. Its unique mechanism of action expands the utility of the medication to a variety of conditions. We continue our series, Therapeutic Cheat Sheet, with a closer look at IVIG, which is FDA-approved for the treatment of dermatologic conditions including dermatomyositis, Kawasaki disease, ITP, and … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Arisa Ortiz, director of laser and cosmetic dermatology at UC San Diego Health. Dr. Ortiz shares why it’s important to set realistic expectations with patients who are seeking treatment for their acne scars. Watch as she outlines her approach for each type of scar, and shares a simple … 
An elderly man presents with generalized erythroderma, as shown. Upon standing, only the patient’s abdominal creases are spared from erythroderma. The patient has peripheral eosinophilia. Which of the following is the most likely diagnosis?
A. Drug reaction with eosinophils and systemic symptoms (DRESS)
B. Mastocytosis
C. Papuloerythroderma of Ofuji
D. Pityriasis rubra pilaris
… 
INTRODUCTION
Alopecia areata (AA) is a condition characterized by nonscarring hair loss. Cases of alopecia areata are most commonly seen in patients under age 30 and are frequently idiopathic. In this report, we discuss a woman in her 50s who developed AA shortly after receiving the Tdap vaccine and after one year of guselkumab therapy.
CASE
A woman in her 50s with history of psor …